Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 449 across all filing types
Latest filing 2024-09-05 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Investor Webinar Presentation 06 Sep 24 22 pages 4.0MB
Regulatory Filings
2024-09-05 English
Bio-Gene & Rallis achieve key Flavocide production milestone 4 pages 297.3KB
Regulatory Filings
2024-09-01 English
Investor Webinar - Shareholder update 06 SEP 24 1 p
Regulatory Filings
2024-09-01 English
Appendix 4E and 2024 Annual Report 73 pages 1.9MB
Regulatory Filings
2024-08-27 English
Appendix 4G and 2024 Corporate Governance Statement 25 pages 461.3KB
Regulatory Filings
2024-08-27 English
Envu collaboration on Flavocide for mosquito management 3 pages 201.1KB
Regulatory Filings
2024-08-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.